Abstract.
Objective and design: Determine the sources of nitric oxide (NO) and evaluate its role in the activation of nuclear Factor-kappaB (NF-κB) and activator protein-1 (AP-1) and in the expression of NO synthase II (NOS II), induced by interleukin-1β (IL-1).¶Material or subjects: Primary cultures of bovine articular chondrocytes.¶Treatment: The cells were treated with IL-1, 5 ng/ml with or without the NO donor S-nitroso-N-acetylpenicillamine (SNAP), in concentrations ranging from 10 to 300 μM.¶Methods: NF-κB and AP-1 activation were evaluated by electrophoretic mobility shift assay. Northern blot was used to detect NOS II mRNA levels and western blot to evaluate IκB-α, NOS I and NOS II protein levels.¶Results: Under basal conditions, chondrocytes expressed NOS I, which was lost upon IL-1 treatment. SNAP inhibited IL-1-induced NF-κB activation and NOS II expression. When added alone, SNAP induced AP-1 activation to approximately the same extent as IL-1.¶Conclusions: These results suggest that, in chondrocytes, NO is a key regulator of the signaling pathways leading from IL-1 to NF-κB and AP-1 activation and to the expression of genes that are involved in the pathophysiology of arthritic diseases.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 13 February 2002; accepted by W. B. van den Berg 2 April 2002
Rights and permissions
About this article
Cite this article
Mendes, A., Carvalho, A., Caramona, M. et al. Role of nitric oxide in the activation of NF-κB, AP-1 and NOS II expression in articular chondrocytes. Inflamm. res. 51, 369–375 (2002). https://doi.org/10.1007/PL00000317
Issue Date:
DOI: https://doi.org/10.1007/PL00000317